Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1638)	3/28/2006 2:52:41 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

IMMC Is also trading above its Feb.-March Hs, continuing the upmove that started on March 22 with good volume of 624,439 Today's volume so far is 340,405 The stock started with an upgap and traded at 4.20 at 10.45AM after some good upticks, but since then has been brought back some & is trading at 3.94 at present. It hasn't closed its early upgap. bigcharts.marketwatch.com It announced today an extension of its Agreement with PFE under which it will collaborates to develop new reagents designed to detect certain undisclosed antigens on circulating tumor cells. The stock needs to close above $5 in order to get off its longer term downtrend.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1638)	1/17/2008 7:46:05 PM
From: Jibacoa	Respond to of 3722

HITK was up for 2nd day on a roll. Yesterday the FDA granted it final approval to the generic version of GSK's nasal spray Flonase for the management of nasal allergy symptoms & today it received an analyst "upgrade" from neutral to buy.<g> The stock was able to close above its Nov-Jan Hs. bigcharts.marketwatch.com But with its lower revenues & higher losses in the first 2Qs, it seems that it won't be able to deal with the resistance above $12.<g> bigcharts.marketwatch.com Bernard